Skip to main content

Creative Planning

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in MDGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,059,281
+$775,024 QoQ
Shares Held
13,147
+9.5% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#105
of 411 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Derivatives in MDGL

reported options exposure · as of Mar 31, 2024
CallValue
$3,562
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. MDGL ranks #18 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MDGL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,059,281 13,147
2026-03-31 $6,284,257 12,005
2025-12-31 $6,487,849 11,141
2025-09-30 $3,866,503 8,430
2025-06-30 $1,562,227 5,162
2025-03-31 $2,439,177 7,364
2024-12-31 $1,367,273 4,431
2024-09-30 $700,113 3,299
2024-06-30 $899,871 3,212
2024-03-31 $608,049 2,277
2024-03-31 $3,562 400
2023-12-31 $429,903 1,858
2023-09-30 $302,886 2,074